(Q33397450)

26 July 2017

title

Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy (English)

1 reference

atypical hemolytic uremic syndrome

26 July 2017

1 reference

1 reference

5

Matthias Frosch

1 reference

26 July 2017

Manuela Zlamy

1

1 reference

26 July 2017

Johannes Hofer

2

1 reference

26 July 2017

Johannes Elias

3

1 reference

26 July 2017

Ulrich Vogel

4

1 reference

26 July 2017

Therese Jungraithmayr

6

1 reference

26 July 2017

Lothar Bernd Zimmerhackl

7

1 reference

26 July 2017

Martina Prelog

8

1 reference

26 July 2017

publication date

4 October 2011

1 reference

Pediatric Transplantation

26 July 2017

published in

1 reference

26 July 2017

volume

16

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

E246-50

1 reference

Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Clinical practice. Today's understanding of the haemolytic uraemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Renal transplantation in HUS patients with disorders of complement regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Atypical haemolytic uraemic syndrome and mutations in complement regulator genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Eculizumab for congenital atypical hemolytic-uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Complement-targeted therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Immunization in children with chronic renal failure: a practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Meningococcal surrogates of protection--serum bactericidal antibody activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Terminal complement complex (C5b-9) in children with recurrent hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Immunogenicity of conjugate meningococcus C vaccine in pediatric solid organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Immunization in children with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

Eculizumab for Atypical Hemolytic–Uremic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3046.2011.01585.X

10.1111/J.1399-3046.2011.01585.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference